Cabotegravir-Hormone PK/PD Interactions for HIV Prevention

NCT07672717 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

HIV
Prophylaxis
Injectable

Interventions

DRUG: Cabotegravir Injectable Suspension (CAB LA)

Sponsor

Johns Hopkins University

Collaborators

[object Object]